Korro Bio, Inc.KRRONASDAQ
LOADING
|||
Switch Symbol:
Key Metrics
As of 2024• vs 2023
Per Share
Revenue/Share
$0.25
Net Income/Share
$-9.37+82.4%
Operating CF/Share
$-6.73+84.7%
Free CF/Share
$-8.74+82.2%
Cash/Share
$14.14-87.0%
Book Value/Share
$17.98-83.8%
Tangible Book/Share
$17.98-83.8%
Equity/Share
$17.98-83.8%
Interest Debt/Share
$5.02-76.9%
Valuation
Market Cap
$339.61M+352.0%
Enterprise Value
P/E Ratio$328.73M+668.7%
-4.06-339.0%
P/S Ratio149.54
P/OCF Ratio
-5.65-406.2%
P/FCF Ratio
P/B Ratio-4.36-335.4%
2.12+378.8%
P/TB Ratio
EV/Sales2.12+378.8%
144.75
EV/EBITDA
-3.72-620.8%
Profitability
Earnings Yield-24.61%+77.2%
FCF Yield-22.96%+77.0%
ROE-52.10%-9.1%
ROIC-43.24%-4.4%
Return on Tangible Assets-36.94%-0.9%
Capital Allocation
CapEx/OCF
-29.80%-155.9%
CapEx/Revenue
788.29%
CapEx/Depreciation
5.02+132.6%
SBC/Revenue
196.48%
Balance Sheet
Debt/Equity0.28+42.8%
Debt/Assets0.20+32.1%
Net Debt/EBITDA
Current Ratio0.12-92.5%
8.79-0.8%
Interest Coverage0.00x
Income Quality0.72-13.3%
Efficiency
Days Sales Outstanding
273 days
Days Payables Outstanding
0 days
Days Inventory
0 days
Receivables Turnover
1.34x
Payables Turnover
0.00x
Inventory Turnover
0.00x
Special Valuations
Graham Number
--
Graham Net-Net
$6.90-90.8%